U.S. generic pharmaceutical industry top acquisitions 2015
This statistic shows the leading U.S. generic pharmaceutical industry acquisitions of 2015, in billion U.S. dollars. In that year, the acquisition of Allergan's generic business by Teva for some 40 billion dollars was the biggest acquisition of the year.
